Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer.

Collina F, La Sala L, Liotti F, Prevete N, La Mantia E, Chiofalo MG, Aquino G, Arenare L, Cantile M, Liguori G, Di Gennaro F, Pezzullo L, Losito NS, Vecchio G, Botti G, Melillo RM, Franco R.

Cancers (Basel). 2019 Jun 7;11(6). pii: E785. doi: 10.3390/cancers11060785.

2.

Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules.

Marotta V, Russo G, Gambardella C, Grasso M, La Sala D, Chiofalo MG, D'Anna R, Puzziello A, Docimo G, Masone S, Barbato F, Colao A, Faggiano A, Grumetto L.

Chemosphere. 2019 Mar;218:885-894. doi: 10.1016/j.chemosphere.2018.11.084. Epub 2018 Nov 17.

PMID:
30609493
3.

Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion.

Muscarella LA, Turchetti D, Fontana A, Baorda F, Palumbo O, la Torre A, de Martino D, Franco R, Losito NS, Repaci A, Pagotto U, Cinque L, Copetti M, Chiofalo MG, Pezzullo L, Graziano P, Scillitani A, Guarnieri V.

Oncotarget. 2018 Apr 17;9(29):20721-20733. doi: 10.18632/oncotarget.25067. eCollection 2018 Apr 17.

4.

Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome.

Chiofalo MG, D'Anna R, Di Gennaro F, Setola SV, Marotta V.

Endocrine. 2018 Oct;62(1):71-75. doi: 10.1007/s12020-018-1622-4. Epub 2018 May 10.

PMID:
29749566
5.

Rapid methods to create a positive control and identify the PAX8/PPARγ rearrangement in FNA thyroid samples by molecular biology.

Vuttariello E, Biffali E, Pannone R, Capiluongo A, Monaco M, Sica V, Aiello C, Matuozzo M, Chiofalo MG, Botti G, Chiappetta G.

Oncotarget. 2018 Apr 10;9(27):19255-19262. doi: 10.18632/oncotarget.24995. eCollection 2018 Apr 10.

6.

The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study.

Faggiano A, Modica R, Severino R, Camera L, Fonti R, Del Prete M, Chiofalo MG, Aria M, Ferolla P, Vitale G, Pezzullo L, Colao A.

Endocrine. 2018 Oct;62(1):46-56. doi: 10.1007/s12020-018-1583-7. Epub 2018 Mar 23.

PMID:
29572709
7.

Predictivity of clinical, laboratory and imaging findings in diagnostic definition of palpable thyroid nodules. A multicenter prospective study.

Chiofalo MG, Signoriello S, Fulciniti F, Avenia N, Ristagno S, Lombardi CP, Nicolosi A, Pelizzo MR, Perigli G, Polistena A, Panebianco V, Bellantone R, Calò PG, Boschin IM, Badii B, Di Maio M, Gallo C, Perrone F, Pezzullo L.

Endocrine. 2018 Jul;61(1):43-50. doi: 10.1007/s12020-018-1577-5. Epub 2018 Mar 22.

8.

Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.

Marotta V, Sciammarella C, Chiofalo MG, Gambardella C, Bellevicine C, Grasso M, Conzo G, Docimo G, Botti G, Losito S, Troncone G, De Palma M, Giacomelli L, Pezzullo L, Colao A, Faggiano A.

Endocr Relat Cancer. 2017 Sep;24(9):485-493. doi: 10.1530/ERC-17-0085. Epub 2017 Jul 10.

PMID:
28696209
9.

Accuracy of Fine Needle Cytology in Histological Prediction of Papillary Thyroid Carcinoma Variants: a Prospective Study.

Cipolletta Campanile A, Malzone MG, Losito NS, Botti G, Chiofalo MG, Faggiano A, Siciliano R, Colao A, Pezzullo L, Fulciniti F.

Endocr Pathol. 2017 Sep;28(3):187-197. doi: 10.1007/s12022-017-9488-1.

PMID:
28639242
10.

Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.

Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Pivonello R, Pezzullo L, Botti G, Colao A, Faggiano A.

Endocrine. 2017 Sep;57(3):544. doi: 10.1007/s12020-017-1269-6. No abstract available.

PMID:
28243971
11.

Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.

Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Pivonello R, Pezzullo L, Botti G, Colao A, Faggiano A.

Endocrine. 2017 Sep;57(3):539-543. doi: 10.1007/s12020-016-1200-6. Epub 2016 Dec 16. No abstract available. Erratum in: Endocrine. 2017 Feb 27;:.

PMID:
27981515
12.

Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.

Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Gambardella C, Grasso M, Antonino A, Annunziata A, Macchia PE, Pivonello R, Santini L, Botti G, Losito S, Pezzullo L, Colao A, Faggiano A.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):661-671. doi: 10.1210/jc.2016-2555.

PMID:
27849428
13.

Follicular thyroid carcinoma with skull metastases.

Chiofalo MG, Setola SV, Di Gennaro F, Fulciniti F, Catapano G, Losito NS, Sandomenico F, Catalano O, Pezzullo L.

Endocr J. 2015;62(4):363-9. doi: 10.1507/endocrj.EJ14-0553. Epub 2015 Mar 20.

14.

Combined papillary and mucoepidermoid carcinoma of the thyroid gland: a possible collision tumor diagnosed on fine-needle cytology. Report of a case with immunocytochemical and molecular correlations.

Fulciniti F, Vuttariello E, Calise C, Monaco M, Pezzullo L, Chiofalo MG, Di Gennaro F, Malzone MG, Campanile AC, Losito NS, Botti G, Chiappetta G.

Endocr Pathol. 2015 May;26(2):140-4. doi: 10.1007/s12022-015-9364-9.

PMID:
25771987
15.

Targeted therapy: a new hope for thyroid carcinomas.

Perri F, Pezzullo L, Chiofalo MG, Lastoria S, Di Gennaro F, Scarpati GD, Caponigro F.

Crit Rev Oncol Hematol. 2015 Apr;94(1):55-63. doi: 10.1016/j.critrevonc.2014.10.012. Epub 2014 Nov 1. Review.

PMID:
25465739
16.

Intraoperative neuromonitoring in thyroid surgery: a point prevalence survey on utilization, management, and documentation in Italy.

Dionigi G, Lombardi D, Lombardi CP, Carcoforo P, Boniardi M, Innaro N, Chiofalo MG, Cavicchi O, Biondi A, Basile F, Zaccaroni A, Mangano A, Leotta A, Lavazza M, Calò PG, Nicolosi A, Castelnuovo P, Nicolai P, Pezzullo L, De Toma G, Bellantone R, Sacco R; Working Group for Neural Monitoring in Thyroid and Parathyroid Surgery in Italy.

Updates Surg. 2014 Dec;66(4):269-76. doi: 10.1007/s13304-014-0275-y. Epub 2014 Dec 3.

PMID:
25465057
17.

Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers.

Cantile M, Scognamiglio G, La Sala L, La Mantia E, Scaramuzza V, Valentino E, Tatangelo F, Losito S, Pezzullo L, Chiofalo MG, Fulciniti F, Franco R, Botti G.

Int J Mol Sci. 2013 Nov 1;14(11):21727-40. doi: 10.3390/ijms141121727.

18.

External branch of the superior laryngeal nerve monitoring during thyroid and parathyroid surgery: International Neural Monitoring Study Group standards guideline statement.

Barczyński M, Randolph GW, Cernea CR, Dralle H, Dionigi G, Alesina PF, Mihai R, Finck C, Lombardi D, Hartl DM, Miyauchi A, Serpell J, Snyder S, Volpi E, Woodson G, Kraimps JL, Hisham AN; International Neural Monitoring Study Group.

Laryngoscope. 2013 Sep;123 Suppl 4:S1-14. doi: 10.1002/lary.24301. Review.

PMID:
23832799
19.

Targeted therapy with kinase inhibitors in aggressive endocrine tumors.

Marotta V, Franzese MD, Del Prete M, Chiofalo MG, Ramundo V, Esposito R, Marciello F, Pezzullo L, Carratù A, Vitale M, Colao A, Faggiano A.

Expert Opin Pharmacother. 2013 Jun;14(9):1187-203. doi: 10.1517/14656566.2013.796931. Review.

PMID:
23675883
20.

Half forehead reconstruction with a single rotational scalp flap for dermatofibrosarcoma protuberans treatment.

Mori S, Di Monta G, Marone U, Chiofalo MG, Caracò C.

World J Surg Oncol. 2012 May 6;10:78.

Supplemental Content

Loading ...
Support Center